Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06483217 · ClinicalTrials.gov registry record · NA
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
A NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06483217 is a NA study that has not yet begun recruiting, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 100 participants.
The verdict
NCT06483217, a NA study, has not yet begun recruiting, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The main questions it aims to answer are: * Does the time between repeat injections differ from the 6-month standard when it is based on patient symptoms alone? * Does symptom control or patient satisfaction change when patients control their own follow up times? Participants will undergo standard botulinum toxin injection into the bladder for OAB treatment and will then be randomly assigned to follow up either at a standard 6-month interval or whenever they feel their symptoms return.
Interventions
- BEHAVIORAL Patient-directed follow up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07 |
| Est. Completion | 2025-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06483217
The ClinicalTrials.gov registry entry for NCT06483217 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient-directed follow up is the first listed.
NCT06483217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06483217 about?
NCT06483217 is a clinical study titled "Optimal Injection Interval for Intra-Detrusor Botulinum Toxin". The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The main questions it aims to answer are: * Does the time between repeat injections differ from the 6-m...
What is the current status of trial NCT06483217?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-07. Estimated completion is 2025-10.
What interventions are being tested in trial NCT06483217?
The interventions under investigation include: Patient-directed follow up (BEHAVIORAL).
Who is sponsoring clinical trial NCT06483217?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.